Every industry moves through a life cycle, starting with the seed of an idea, experiencing rapid growth periods, and ultimately settling into a mature phase. The Pharmaceutical industry has reached maturity, and with this maturity has come aggressive competition, reducing margins and ratcheting up pressure on cost and product development timelines. In addition to market share, Pharmaceutical companies compete for investor capital, and this competition drives industry leaders to demonstrate greater and greater control over their deployment of these scarce dollars.

To read more go to http://digital.pharmpro.com/pharmaceuticalproducts/ips_tour_february_2014?pg=20#pg20